Nicholls, S.J.Nerlekar, N.2021-07-302021-07-302021JACC Cardiovascular Imaging, 2021; 14(6):1174-11761936-878X1876-7591http://hdl.handle.net/2440/131376Abstract not availableen© 2021 by The American College of Cardiology Foundation published by ElsevierCMRSGLT2 inhibitorscardiovascularclinical trialsinterstitialCan CMR elucidate the cardiovascular benefit of SGLT2 inhibitors?Journal article100003435910.1016/j.jcmg.2020.11.0030006589411000112-s2.0-85099947931562982Nicholls, S.J. [0000-0002-9668-4368]